FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

Celldex Therapeutics, Inc.: cash_and_equivalents

One fact, its scope and the complete path back to the official record.

Period: as of 2012-03-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/3d48fa83-76fd-438f-9aec-56a7d97fc6b3

Reported value

$22.755M{"amount": 22755000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Entity
Celldex Therapeutics, Inc.
Metric
cash_and_equivalents
Period
as of 2012-03-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001104659-12-032960 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T07:49:48.216012+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0000744218/cash-and-equivalents/2012-03-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.